You have 9 free searches left this month | for more free features.

abi-007

Showing 1 - 21 of 21

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Melanoma Trial in Houston (ABI-007, Ipilimumab, Phone Call)

Completed
  • Melanoma
  • ABI-007
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 12, 2022

Hemodialysis Graft Dysfunction Trial in United States (ABI-007)

Terminated
  • Hemodialysis Graft Dysfunction
  • ABI-007
  • Peoria, Illinois
  • +3 more
Nov 14, 2019

Metastatic Breast Cancer Trial in Kiev (ABI-007, Docetaxel)

Completed
  • Metastatic Breast Cancer
  • Kiev, Ukraine
    Study Sites in Russia and the Ukraine
Nov 7, 2019

Fallopian Tube Tumors, Peritoneal Tumors, Ovarian Tumors Trial in Houston (ABI-007, Carboplatin)

Terminated
  • Fallopian Tube Neoplasms
  • +2 more
  • Houston, Texas
    University of Texas, MD Anderson Cancer Center
Oct 16, 2019

Metastatic Breast Cancer Trial in United States (ABI-007, Bevacizumab)

Completed
  • Metastatic Breast Cancer
  • Melbourne, Florida
  • +19 more
Nov 13, 2019

Breast Cancer Trial in United States (Adriamycin and Cytoxan (AC), ABI-007, Taxol)

Completed
  • Breast Cancer
  • Adriamycin and Cytoxan (AC)
  • +4 more
  • Birmingham, Alabama
  • +26 more
Nov 7, 2019

Urinary Bladder Tumors, Carcinoma, Transitional Cell, Ovarian Tumors Trial in Worldwide (CC-486, Carboplatin, ABI-007)

Completed
  • Urinary Bladder Neoplasms
  • +7 more
  • Scottsdale, Arizona
  • +12 more
Nov 7, 2019

Colorectal Tumors Trial in France (ABI-007)

Completed
  • Colorectal Neoplasms
  • ABI-007
  • Lille 59, France
  • +5 more
Apr 10, 2020

Metastatic Breast Cancer Trial in Canada (ABI-007)

Terminated
  • Metastatic Breast Cancer
  • ABI-007
  • Burnaby, British Columbia, Canada
  • +13 more
Nov 7, 2019

Malignant Melanoma Trial in Worldwide (ABI-007, Dacarbazine)

Completed
  • Malignant Melanoma
  • Birmingham, Alabama
  • +111 more
Oct 16, 2019

Collect Survival Data on Patients Previously Enrolled in

Completed
  • Pancreatic Cancer
  • ABI-007
  • Scottsdale, Arizona
  • +38 more
Oct 30, 2019

Breast Cancer Trial in United States (bevacizumab, Carboplatin, ABI-007)

Completed
  • Breast Cancer
  • bevacizumab
  • +2 more
  • Downers Grove, Illinois
  • +5 more
Aug 16, 2017

Melanoma, Metastases Trial in Durham (ABI-007)

Completed
  • Melanoma
  • Metastases
  • ABI-007
  • Durham, North Carolina
    Abraxis BioScience Inc.
Apr 25, 2017

Metastatic Pancreatic Cancer Trial in France (ABI-007, Gemcitabine, simplified LV5FU2)

Unknown status
  • Metastatic Pancreatic Cancer
  • ABI-007
  • +2 more
  • Angers, France
  • +14 more
Jan 30, 2017

Breast Tumors, Metastases, Tumor Trial in Raleigh (ABI-007)

Completed
  • Breast Neoplasms
  • Metastases, Neoplasm
  • ABI-007
  • Raleigh, North Carolina
    Abraxis BioScience, Inc.
Dec 14, 2016

NSCLC Trial in New York (ABI-007)

Completed
  • Non-Small Cell Lung Cancer
  • ABI-007
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Dec 14, 2016

Tumors, Metastases, Tumor Trial in Durham (ABI-007)

Completed
  • Neoplasms
  • Metastases, Neoplasm
  • ABI-007
  • Durham, North Carolina
    Abraxis Bioscience, Inc.
Nov 23, 2016

Head Neck Cancer Trial in Toronto (ABI-007)

Completed
  • Head and Neck Cancer
  • ABI-007
  • Toronto, Ontario, Canada
    Princess Margaret Hospital
Jun 21, 2016

Bladder Cancer Trial in Ann Arbor (ABI-007, Carboplatin, Gemcitabine)

Completed
  • Bladder Cancer
  • ABI-007
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan
Nov 3, 2015

Gastric Cancer Trial in Japan (ABI-007)

Completed
  • Gastric Cancer
  • ABI-007
  • Nagoya, Aichi, Japan
  • +9 more
Jan 16, 2012

Breast Tumors, Metastases, Tumor Trial in Durham (ABI-007)

Completed
  • Breast Neoplasms
  • Metastases, Neoplasm
  • ABI-007
  • Durham, North Carolina
    Abraxis Bioscience, Inc
Jul 12, 2006